Effect of CoolSense and EMLA Cream on Pain During Intravenous Cannulation in Pediatric Population: A Randomized, Controlled Trial.
CoolSense
EMLA
Intravenous cannulation
Pediatrics
Journal
Indian journal of pediatrics
ISSN: 0973-7693
Titre abrégé: Indian J Pediatr
Pays: India
ID NLM: 0417442
Informations de publication
Date de publication:
29 Jun 2022
29 Jun 2022
Historique:
received:
24
12
2021
accepted:
29
03
2022
entrez:
29
6
2022
pubmed:
30
6
2022
medline:
30
6
2022
Statut:
aheadofprint
Résumé
To compare the efficacy of CoolSense and EMLA cream on pain reduction during intravenous cannulation in the pediatric population. A total of 140 American Society of Anesthesiologist I/II children of 6-12 y requiring intravenous cannulation before induction of anesthesia were randomized into two groups of 70 each. Before intravenous cannulation, group I received CoolSense pretreatment while group II received EMLA cream pretreatment. The primary outcome was to assess the efficacy of CoolSense and EMLA cream on pain reduction during intravenous cannulation. The secondary outcomes included the anxiety level of children, successful first attempt at cannulation, technical difficulties faced, adverse reactions, and parents' satisfaction score. There was a significant reduction in pain scores during intravenous cannulation in the CoolSense group compared to the EMLA cream group (mean pain score 7.14 ± 4.322 versus 29.32 ± 8.95, p value 0.001). Comparison of pre- and postprocedural anxiety levels showed a decrease in the anxiety level in the CoolSense group (p value = 0.003) as compared to the EMLA group. The duration of application of CoolSense was significantly less than EMLA cream. CoolSense was more efficacious in reducing the pain of intravenous cannulation than the EMLA cream. In the pediatric population, CoolSense appears to be a simple and rapid means of providing adequate analgesia for venous cannulation.
Identifiants
pubmed: 35767175
doi: 10.1007/s12098-022-04233-w
pii: 10.1007/s12098-022-04233-w
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2022. The Author(s), under exclusive licence to Dr. K C Chaudhuri Foundation.
Références
Cummings EA, Reid GJ, Finley GA, McGrath PJ, Ritchie JA. Prevalence and source of pain in pediatric inpatients. Pain. 1996;68:25–31.
doi: 10.1016/S0304-3959(96)03163-6
Duff AJ. Incorporating psychological approaches into routine pediatric venepuncture. Arch Dis Child. 2003;88:931–7.
doi: 10.1136/adc.88.10.931
Taddio A, Soin HK, Schuh S, Koren G, Scolnik D. Liposomal lidocaine to improve procedural success rates and reduce procedural pain among children: a randomized controlled trial. CMAJ. 2005;172:1691–5.
Harrison N, Langham BT, Bogod DG. Appropriate use of local anesthetic for venous cannulation. Anaesthesia. 1992;47:210–2.
doi: 10.1111/j.1365-2044.1992.tb02120.x
Singer AJ, Taira BR, Chisena EN, Gupta N, Chipley J. Warm lidocaine ⁄tetracaine patch versus placebo before pediatric intravenous cannulation: a randomized controlled trial. Ann Emerg Med. 2008;52:41–7.
doi: 10.1016/j.annemergmed.2008.01.336
Costello M, Ramundo M, Christopher NC, Powell KR. Ethyl vinyl chloride vapocoolant spray fails to decrease pain associated with intravenous cannulation in children. Clin Pediatr (Phila). 2006;45:628–32.
doi: 10.1177/0009922806291013
Timmermans MW, Bruynzeel DP, Rustemeyer T. Allergic contact dermatitis from EMLA cream: concomitant sensitisation to both local anesthetics lidocaine and prilocaine. J Dtsch Dermatol Ges. 2009;7:237–8.
pubmed: 19054423
Wainstein J, Chimin G, Landau Z, et al. The use of a CoolSense device to lower pain sensation during finger pricking while measuring blood glucose in diabetes patients - a randomized placebo. Diabetes Technol Ther. 2013;15:688–94.
Ragg PG, Cahoon G, Yeo A, Chalkiadis G. A clinical audit to assess the efficacy of the coolsense ® pain numbing applicator for intravenous cannulation in children. Anaesth Intensive Care. 2017;45:251–5.
doi: 10.1177/0310057X1704500216
Skiveren J, Kjaerby E, Nordahl LH. Cooling by frozen gel pack as pain relief during treatment of axillary hyperhidrosis with botulinum toxin a injection. Acta Derm Venereol. 2008;88:366–9.
pubmed: 18709307
Goodenough B, Thomas W, Champion GD, et al. Unravelling age effects and sex differences in needle pain: ratings of sensory intensity and unpleasantness of venipuncture pain by children and their parents. Pain. 1999;80:179–90.
doi: 10.1016/S0304-3959(98)00201-2
Goudra BG, Galvin E, Singh PM, Lions J. Effect of site selection on pain of intravenous cannula insertion: a prospective randomised study. Indian J Anaesth. 2014;58:732–5.
doi: 10.4103/0019-5049.147166
Weisman SJ, Bernstein B, Schechter NL. Consequences of inadequate analgesia during painful procedures in children. Arch Pediatr Adolesc Med. 1998;152:147–9.
doi: 10.1001/archpedi.152.2.147
Alsantali A. A comparative trial of ice application versus EMLA cream in alleviation ofpain during botulinum toxin injections for palmar hyperhidrosis. Clin Cosmet Investig Dermatol. 2018;11:137–40.
doi: 10.2147/CCID.S155023
Kanni T, Agiasofitou E, Markantoni V, et al. Cryoanalgesia with a coolsense device in patients treated with botulinum toxin-a for palmar-plantar hyperhidrosis: a self-controlled study. Skin Appendage Disord. 2019;5:119–20.
doi: 10.1159/000492239